Impact of faricimab and high-dose aflibercept on treatment demand in a tertiary ophthalmic centre in Norway.

چکیده

To evaluate the impact of introducing faricimab and high-dose aflibercept on intravitreal injection (IVI) demand and treatment costs for retinal diseases in a large tertiary retina centre. This retrospective longitudinal registry study included all anti-VEGF treatment episodes at Oslo University…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• درمان های ضد VEGF